Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 201 M207 M218 M211 M209 M203 M 841 M Research & development —————— — Operating income -654 M-246 M538 M17 M-612 M2.76 B 2.7 B Non-Operating Income, Total -237 M65 M140 M355 M-105 M35 M 425 M Interest expense, net of interest capitalized 128 M129 M122 M125 M123 M121 M 491 M Non-Operating Income, excl. Interest Expenses -365 M-64 M18 M230 M-228 M-86 M -66 M Unusual income/expense —————— — Pretax income -654 M-246 M538 M17 M-612 M-386 M -443 M Equity in earnings —————— — Taxes -74 M-45 M127 M-27 M-49 M2 M 53 M Non-controlling/minority interest -158 M-36 M124 M43 M-104 M-33 M 30 M After tax other income/expense —————— — Net income before discontinued operations -422 M-165 M287 M1 M-459 M-355 M -526 M Discontinued operations —————— — Net income -422 M-165 M287 M1 M-459 M-355 M -526 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -422 M-165 M287 M1 M-459 M-355 M -526 M Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) —————— — Average basic shares outstanding —————— — Diluted shares outstanding —————— — EBITDA -536 M-114 M696 M212 M-489 M-262 M 157 M EBIT -654 M-246 M538 M17 M-612 M-386 M -443 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 118 M132 M158 M195 M123 M124 M 600 M